Free radicals trigger TNFα-induced cardioprotection

[1]  R. Bolli,et al.  Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning. , 2004, Journal of molecular and cellular cardiology.

[2]  J. McMurray,et al.  Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) , 2004, Circulation.

[3]  K. Shimamoto,et al.  The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning. , 2004, Cardiovascular research.

[4]  N. Khaper,et al.  Antioxidant enzyme gene expression in congestive heart failure following mycardial infarction , 2003, Molecular and Cellular Biochemistry.

[5]  N. Maulik,et al.  Preconditioning potentiates redox signaling and converts death signal into survival signal. , 2003, Archives of biochemistry and biophysics.

[6]  M. Marber,et al.  Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. , 2003, Journal of molecular and cellular cardiology.

[7]  J. Downey,et al.  Preconditioning the myocardium: from cellular physiology to clinical cardiology. , 2003, Physiological reviews.

[8]  D. Harrison,et al.  Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation , 2003, Circulation.

[9]  A. Takeshita,et al.  Oxidative Stress Mediates Tumor Necrosis Factor-&agr;–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes , 2003, Circulation.

[10]  P. Ferdinandy,et al.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia‐reperfusion injury and preconditioning , 2003, British journal of pharmacology.

[11]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[12]  M. Sack,et al.  Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene. , 2002, Cardiovascular research.

[13]  L. Opie,et al.  Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. , 2002, Journal of molecular and cellular cardiology.

[14]  M. Sack.  Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease , 2002 .

[15]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Fink,et al.  A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. , 2000, Free radical biology & medicine.

[17]  J. Horiot,et al.  Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat. , 1999, Free radical biology & medicine.

[18]  E. Bassenge,et al.  Detection of superoxide radicals and peroxynitrite by 1-hydroxy-4-phosphonooxy-2,2,6,6-tetramethylpiperidine: quantification of extracellular superoxide radicals formation. , 1998, Biochemical and biophysical research communications.

[19]  M. Chiariello,et al.  Oxygen radicals can induce preconditioning in rabbit hearts. , 1997, Circulation research.

[20]  E. Bassenge,et al.  Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6, 6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. , 1997, Biochemical and biophysical research communications.

[21]  J. Downey,et al.  Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. , 1997, Journal of molecular and cellular cardiology.

[22]  J. Gurevitch,et al.  Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. , 1996, Journal of the American College of Cardiology.

[23]  D. Das,et al.  Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. , 1993, Cardiovascular research.

[24]  J. McMurray,et al.  Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.

[25]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.